Oct 4 |
Xencor Announces Upcoming Change to Board of Directors
|
Sep 12 |
Xencor Announces Closing of Public Offering Including Full Exercise of Underwriters’ Option to Purchase Additional Shares
|
Sep 12 |
Xencor: Vudalimab Development Along With Hidden Gem Candidate
|
Sep 12 |
Xencor (XNCR) Surges 10.5%: Is This an Indication of Further Gains?
|
Sep 11 |
Xencor stock falls after it prices $175M public offering
|
Sep 11 |
Xencor Announces Pricing of $175 Million Public Offering of Common Stock
|
Sep 10 |
Xencor announces public offering of common stock
|
Sep 10 |
Xencor Announces Proposed Public Offering of Common Stock
|
Sep 10 |
Xencor Stock Gains 23% on Encouraging Pipeline Advancements
|
Sep 9 |
Xencor stock rallies 24% amid drug development updates
|